Warburg seeks more than $10 bln in Bausch & Lomb sale-source
NEW YORK Dec 11 (Reuters) - Warburg Pincus LLC has mandated Goldman Sachs Group Inc to explore a sale of eye care company Bausch & Lomb Inc, hoping to fetch more than $10 billion, a person familiar with the matter said on Tuesday.
The private equity firm has asked Goldman to approach potential buyers for Bausch & Lomb Inc, including major healthcare companies, but could also turn to an initial public offering as an alternative, the source said on condition of anonymity because discussions are confidential.
"Bausch & Lomb is regularly contacted by companies with strategic interest in our company, and we continue to aspire to a return to the public markets in the future," said Bausch & Lomb spokesman Adam Grossberg. "However, our focus remains on building the best global eye-health company, and therefore won't comment further".
Warburg Pincus and Goldman Sachs declined to comment. Bloomberg News reported on Goldman Sachs' appointment to sell Bausch & Lomb earlier on Tuesday.
- U.S. nurse defies Maine's Ebola quarantine, takes bike ride |
- Clashes erupt as Israeli police kill Palestinian suspected of shooting Jewish far-rightist
- SoftBank's humanoid robot lands job as Nescafe salesman
- Ukraine gas supplies in doubt as Russia seeks EU payment deal
- Apple's Cook: 'I'm proud to be gay'